AI for Clinical Trial Matching: Feasibility and Recruitment Guide
Evaluate AI for clinical trial matching, protocol feasibility, patient identification, site selection, and real-world evidence workflows.
Representative source image: official TriNetX product page.
Quick answer: AI for clinical trial matching can help teams search records, estimate feasibility, identify candidate sites, and prioritize potentially eligible patients. It should not trigger outreach, enrollment, protocol changes, or evidence claims without study-team, privacy, IRB, and clinician review.
Who this guide is for
Clinical research operations, sponsors, CROs, health systems, investigators, and real-world evidence teams.
What makes this workflow different
Clinical trial matching needs source-traceable eligibility logic, privacy review, IRB alignment, and human confirmation before outreach.
What to verify before using it
Map inclusion and exclusion logic to source records or coded concepts.
Confirm consent, IRB, recruitment-contact, and sponsor data-use rules before outreach.
Validate eligibility matches against local charts and study-team review.
Audit missing data, temporality, negation, biomarkers, medications, and false positives.
Track site, diversity, and enrollment assumptions after launch.
Risk level and safe use
Medical risk
High
Best first step
Write the workflow in one sentence, decide who reviews the AI output, and test with a small controlled pilot before expanding.
Recommended posture
Use AI as supervised workflow support. Verify sources, privacy, human review, and regulatory fit before relying on outputs.
Source-backed products for this workflow
These profiles are not rankings. They are starting points for checking vendor claims, privacy terms, FDA or regulatory posture, evidence, and workflow fit.
Azra AI describes enterprise solutions that identify, connect, and manage patients across clinical workflows, with oncology pages stating that the platform ingests pathology reports and clinical records in real time, identifies positive cancer diagnoses, structures cases by cancer type, and extracts details such as stage, grade, and tumor markers. Registry pages describe automated case finding with human-in-the-loop validation, and clinical-research pages describe EMR, notes, and PDF aggregation with traceable pre-screening citations. Elekta announced an April 2025 partnership combining Azra's real-time patient identification and workflow automation with Elekta ONE Registry Informatics for cancer registry operations.
Best for
Cancer programs that need real-time case finding, registry automation, navigation queues, tumor-board preparation, or clinical-trial pre-screening while preserving human review and oncology-team accountability.
First check
Which Azra workflow is in scope: oncology, registry automation, clinical trials, incidental findings, high-risk screening, multidisciplinary meetings, enterprise analytics, or embedded navigation services.
Tempus describes Tempus One as a generative AI-enabled assistant for healthcare providers and researchers that can surface patient insights from clinical and molecular data, support EHR workflows, summarize histories and biomarkers, search trials, and process unstructured multimodal data; Tempus announcements also describe EHR integration, guideline access, documentation support, and custom agent-building capabilities.
Best for
Oncology and precision-medicine teams that need governed access to Tempus patient insights, test status, guideline context, trial matching, and multimodal data summaries.
First check
Whether Tempus One is being used in Hub, an EHR integration, Lens, a provider workflow, or a life-sciences research workflow.
Caris describes itself as a molecular science and AI company focused on precision medicine, and has announced Caris AI Insights signatures used in molecular tumor board reporting.
Best for
Oncology teams evaluating molecular profiling and AI-assisted insight workflows for cancer care and research.
First check
Which test, report, or AI insight is being used and its exact clinical role.
ConcertAI describes integrated oncology real-world data, AI innovation, and clinical expertise across real-world evidence, accelerated clinical trials, commercial solutions, CancerLinQ, and the Precision Suite, including generative AI for RWE analysis and smarter clinical-trial decisions.
Best for
Oncology sponsors, CROs, research networks, and cancer programs that need governed real-world evidence or trial intelligence built around oncology data.
First check
Which ConcertAI product is in scope: PrecisionExplorer, PrecisionTRIALS, PrecisionGTM, Precision360, CancerLinQ, or a trial operations workflow.
Sources
3 official sources
Official source trail for this workflow
Open these vendor, documentation, privacy, or regulatory sources before relying on product claims, especially for FDA status, PHI handling, deployment model, and intended use.
Find the best AI for medical workflows by matching the tool to documentation, questions, diagnosis support, research, coding, billing, imaging, or practice operations.
Understand AI for medical diagnosis, including validation evidence, FDA status, clinical supervision, and why patient-specific diagnosis should not rely on general chatbots.
